photo credit @ Androni-Giocattoli
Another Androni-Giocattoli rider has been caught doping, after the UCI today announced today, that Fabio Taborre tested positive for a blood-boosting drug known as FG-4592. The drug was detected in an out-of-competition control on June 16, 2015.
Taborre marks the second such doping case for the Italian team, after Davide Appollonio tested positive for EPO on June 14.
Under the UCI new rules, a second infraction automatically triggers suspension for a team, which can range from 15 to 45 days.
“The UCI will refer the matter to the Disciplinary Commission which will render a decision in the upcoming days,” the UCI announcement stated.
Taborre also personally faces a fine of €100,000 by his team. if his test is confirmed positive.
The banned substance in question, also known as Roxadustat, is still in its clinical trial phase, which sinker to EPO, can directly stimulate the production of red blood cells. However, FG-4592 is taken orally, as opposed to EPO which must be injected into the body.
The World Anti-Doping Agency specifically bans this class of compound under its code.
UCI statement on Fabio Taborre and UCI Professional Continental Team Androni Giocattoli-Sidermec 27 July 2015
The Union Cycliste Internationale (UCI) announces that it has notified Italian rider Fabio Taborre of an Adverse Analytical Finding (AAF) of FG-4592 (*) in a sample collected during an out-of-competition test on 16 June 2015.
The rider has the right to request and attend the analysis of the B sample.
In accordance with UCI Anti-doping Rules (UCI ADR), the rider has been provisionally suspended until the adjudication of the affair.
This constitutes the second AAF for a member of the UCI Professional Continental Team Androni Giocattoli-Sidermec (**) since the beginning of 2015 and within a twelve-month period. Therefore article 7.12.1 UCI ADR providing for the suspension of the Team from 15 to 45 days (***) will be applied.
The UCI will refer the matter to the Disciplinary Commission which will render a decision in the upcoming days.
At this stage of the procedure, the UCI will not comment any further on any of these matters.
(*) FG-4592 is a prohibited substance that has the property of stimulating the endogenous production of EPO.
(**) On 30 June 2015, the UCI Professional Continental Team Androni Giocattoli-Sidermec Italian rider Davide Appollonio was notified of an AAF of EPO in a sample collected during an out-of-competition test on 14 June 2015.
You must be logged in to post a comment.
